Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

 

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19
M

Fox Chase Updates on mRCC: Surveying Options for 1L, 2L and Beyond

By Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19 FEATURING Matthew Zibelman
By Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19 FEATURING Matthew Zibelman
0 views
March 1, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
Videos
10:43
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Update on mUC: 1L, Maintenance, and 2L Treatment Options

Feat. P. Ghatalia
13:36
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Updates on mRCC: Surveying Options for 1L, 2L and Beyond

Feat. M. Zibelman
08:23
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

New Data on Adjuvant vs. Salvage RT for PC: Is Early Salvage the Pre…

Feat. J. Wong
12:55
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

mPC Fox Chase Update: Is There OS Benefit With Abi/Pred + ADT vs. AD…

Feat. F. Anari
11:47
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Experience on COVID-19 & Cancer: Disease Biology, Risk…

Feat. A. Kutikov
16:47
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase COVID-19 Updates on Surgery for Bladder, Kidney & Pros…

Feat. R. Viterbo